Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
SUNLENCA Inj Lös 463.5 mg/1.5ml 2 Durchstf 1.5 ml
Drug
Sunlenca, Injektionslösung
HIV-Infektion
08.03.0. – antivirals
HAM – Human medicine
LSINJ – Solution for injection
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
7/7/2023
7/6/2028
Dosage strength
Sunlenca, Injektionslösung
HIV-Infektion
01
Z – approved
Package
7680683850012
No information made available
A/R – Authorised / referenced
2 vial(s)
001
Z – approved
Declaration
Component
463.5 mg lenacapavirum
lenacapavirum natricum
lenacapavirum natricum
macrogolum 300
aqua ad iniectabile
10.99 mg natrium
aqua ad iniectabile
10.99 mg natrium
Spezialitätenliste***
SL
-
-
20708.65
None
Yes
10%
No
Authorisation holder
7601001379374
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug (ZG)
General-Guisan-Strasse 8
6300 Zug (ZG)
Date of revision of the text
11/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.